Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Protein fragment found to help improve chemotherapy

21.05.2003


USC researchers find ways to improve effectiveness against tumors



Researchers from the Keck School of Medicine of the University of Southern California have isolated a protein fragment derived from the cancer immunotherapy drug interleukin 2 (IL-2) that seems to enhance the uptake of chemotherapeutic agents into tumors.

In fact, says Alan Epstein, M.D., Ph.D., professor of pathology at the Keck School of Medicine, when this patented protein fragment is attached to a tumor-targeting antibody, it can prompt tumors to soak up more than 300 percent the normal amount of chemotherapy drugs. It does this, Epstein says, by making the tumor’s blood vessel walls more "open" or permeable to the drugs. (Blood vessel walls are made of epithelial cells that are usually tightly joined together; when the junctions between those cells loosen up, it becomes easier for molecules to enter or leave the bloodstream.)


This work was described in a paper being published in the May 21, 2003 issue of the Journal of the National Cancer Institute.

The interleukins are part of a class of proteins called cytokines, which play a role in the human immune response. It’s been hoped that interleukin 2 (IL-2) and its brethren might play a central role in cancer immunotherapy-battling cancer by revving up the immune system. Unfortunately, IL-2 can only be tolerated in small doses by the body. Taken at levels that would take advantage of its therapeutic value, it causes wide-spread edema and other problems due to blood vessel leakiness.

While seeking the cause of this leakiness, Epstein and his Keck School of Medicine colleagues isolated a stretch of 37 amino acids on the IL-2 protein; this sequence, he says, "is responsible for 100 percent of the vasopermeability." Dubbed PEP, for permeability-enhancing peptide, the molecule is now being commercially developed by Peregrine Pharmaceuticals of Tustin, Calif.

Having determined that PEP is indeed a permeability enhancer, Epstein and his colleagues took their exploration a step further: They transplanted mice with human tumor cells and pretreated them with monoclonal antibodies coupled with PEP.

When these mice and control mice were later injected with a radiolabeled tracer antibody or drug, there was a three to four fold increase in the amount of the antibody taken up by the tumors of the pretreated mice than those of the control mice.

"We’ve showed that you can use PEP to induce selective and reversible blood vessel permeability at the tumor site to get better drug uptake," says Epstein. "This may turn out to be a hugely important tool in cancer therapy."

The next step, he says, "is to try to get this product ready to test in human patients."


###
This work was supported by grants from the National Cancer Institute, Peregrine Pharmaceuticals, Inc. and Cancer Therapeutics Laboratories.

Alan L. Epstein, Myra Mizokami, Jiali Li, Peisheng Hu, Leslie A. Khawli, "Identification of a Protein Fragment of Interleukin 2 Responsible for Vasopermeability." Journal of the National Cancer Institute, Vol. 95, No. 10, May 21, 2003, pp. 741-749.

Jon Weiner | EurekAlert!
Further information:
http://www.usc.edu/

More articles from Health and Medicine:

nachricht Deep stimulation improves cognitive control by augmenting brain rhythms
04.04.2019 | Picower Institute at MIT

nachricht Black nanoparticles slow the growth of tumors
04.04.2019 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Explosion on Jupiter-sized star 10 times more powerful than ever seen on our sun

A stellar flare 10 times more powerful than anything seen on our sun has burst from an ultracool star almost the same size as Jupiter

  • Coolest and smallest star to produce a superflare found
  • Star is a tenth of the radius of our Sun
  • Researchers led by University of Warwick could only see...

Im Focus: Quantum simulation more stable than expected

A localization phenomenon boosts the accuracy of solving quantum many-body problems with quantum computers which are otherwise challenging for conventional computers. This brings such digital quantum simulation within reach on quantum devices available today.

Quantum computers promise to solve certain computational problems exponentially faster than any classical machine. “A particularly promising application is the...

Im Focus: Largest, fastest array of microscopic 'traffic cops' for optical communications

The technology could revolutionize how information travels through data centers and artificial intelligence networks

Engineers at the University of California, Berkeley have built a new photonic switch that can control the direction of light passing through optical fibers...

Im Focus: A long-distance relationship in femtoseconds

Physicists observe how electron-hole pairs drift apart at ultrafast speed, but still remain strongly bound.

Modern electronics relies on ultrafast charge motion on ever shorter length scales. Physicists from Regensburg and Gothenburg have now succeeded in resolving a...

Im Focus: Researchers 3D print metamaterials with novel optical properties

Engineers create novel optical devices, including a moth eye-inspired omnidirectional microwave antenna

A team of engineers at Tufts University has developed a series of 3D printed metamaterials with unique microwave or optical properties that go beyond what is...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

First dust conference in the Central Asian part of the earth’s dust belt

15.04.2019 | Event News

Fraunhofer FHR at the IEEE Radar Conference 2019 in Boston, USA

09.04.2019 | Event News

 
Latest News

New automated biological-sample analysis systems to accelerate disease detection

18.04.2019 | Life Sciences

Explosion on Jupiter-sized star 10 times more powerful than ever seen on our sun

18.04.2019 | Physics and Astronomy

New eDNA technology used to quickly assess coral reefs

18.04.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>